Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 34.95

-3.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Uncle Mikey who wrote (109)	11/12/1997 3:43:00 AM
From: Gary105	Read Replies (1) of 340

Re. Natwest, Copaxone in best case scenario contributes a little over 30 cents a share to earnings. So if Copaxone does not sell at all, Teviy consensus for next yr goes to about $3.10 (highly unlikely). If it sells modestly, maybe $3.25 and if it sells as planned $3.37 based on consensus. So the impact of Copaxone is overdone - plus it will probably sell. If anyone knows of a pharmaceutical company growing at 50%/yr selling at 15x next years earnings, please let me know. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next